Quality Improvement and Cost Reduction Realized by a Purchaser Through Diabetes Disease Management

Disease Management

Volumn 6, Issue 4, 2003, Pages 233-241

  Snyder, J W ^a   Malaskovitz, J ^b   Griego, J ^b   Persson, J ^b   Flatt, K ^b  

^a Southwest Medical Associates   (United States)

^b HEALTHWAYS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C;

ARTICLE; CLINICAL EXAMINATION; COST CONTROL; DIABETES MELLITUS; HEALTH CARE QUALITY; HEALTH INSURANCE; PATIENT SATISFACTION; REIMBURSEMENT; STATISTICAL ANALYSIS; UNITED STATES;

EID: 0346727275     PISSN: 1093507X     EISSN: None     Source Type: Journal    
DOI: 10.1089/109350703322682540     Document Type: Article

References (42)

1. American Diabetes Association. Clinical practice recommendations 2002. Diabetes Care 2002;25(Suppl 1):S1-S147.
2. Beckles GLA, Engelgau MM, Narayan KMV, Herman WH, Aubert RE, Williamson DF. Population-based assessment of the level of care among adults with diabetes in the U.S. Diabetes Care 1998;21:1432-1438.
3. Kell SH, Drass J, Bausell RB, Thomas KA, Osborn MA, Gohdes D. Measures of disease control in Medicare beneficiaries with diabetes mellitus. J Am Geriatr Soc 1999;47:417-422.
4. National Committee for Quality Assurance. The state of managed care quality 2001, comprehensive diabetes care. Available online at: http://www.ncqa.org/somc2001/diabetes/somc_2001_cdiab.html#performing
5. Clark CM, Snyder JW, Meek RL, et al. A systematic approach to risk stratification and intervention within a managed care environment improves diabetes outcomes and patient satisfaction. Diabetes Care 2001;24:1079-1086.
6. Aubert RE, Herman WH, Waters J, et al. Nurse case management to improve glycemic control in diabetic patients in a health maintenance organization. Ann Intern Med 1998;129:605-612.
7. Peters AL, Davidson MB, Ossorio RC. Management of patients with diabetes by nurses with support of subspecialists. HMO Pract 1995;9:8-13.
8. Sadur CN, Moline N, Costa M, et al. Diabetes management in a health maintenance organization. Efficacy of care management using cluster visits. Diabetes Care 1999;22:2011-2017.
9. McCulloch DK, Price MJ, Hindmarsh M, Wagner EH. A population-based approach to diabetes management in a primary care setting: early results and lessons learned. Eff Clin Pract 1998;1:12-22.
10. Ovhed I, Johansson E, Odeberg H, Råstam L. A comparison of two different team models for treatment of diabetes mellitus in primary care. Scand J Caring Sci 2000;14:253-258.
11. Gray A, Raikou M, McGuire A, et al. Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41). BMJ 2000;320:1373-1378.
12. Ray NF, Thamer M, Gardner E, Chan JK. Economic consequences of diabetes mellitus in the US in 1997. Diabetes Care 1998;21:296-309.
13. Olivera EM, Duhalde EP, Gagliardino JJ. Costs of temporary and permanent disability induced by diabetes. Diabetes Care 1991;14:593-596.
14. Olsson J, Persson U, Tollin C, et al. Comparison of excess costs of care and production losses because of morbidity in diabetic patients. Diabetes Care 1994; 17:1257-1263.
15. Persson U. The indirect costs of morbidity in type II diabetic patients. Pharmacoeconomics 1995;8(Supp1): 28-32.
16. Trief PM, Aquilino C, Paradies K, Weinstock RS. Impact of the work environment on glycemic control and adaptation to diabetes. Diabetes Care 1999;22: 569-574.
17. Prochaska J, DiClemente C. Stages and processes of self-change of smoking: toward an integrative model of change. J Consult Clin Psychol 1983;51:390-395.
18. Boyle RG, O'Connor PJ, Pronk NP, Tan A. Stages of change for physical activity, diet, and smoking among HMO members with chronic conditions. Am J Health Promot 1998;12:170-175.
19. Von Korff M, Gruman J, Schaefer J, Curry SJ, Wagner EH. Collaborative management of chronic illness. Ann Intern Med 1997;127:1097-1102.
20. Glasgow RE, Toobert DJ, Hampson SE, Noell JW. A brief office-based intervention to facilitate diabetes self-management. Health Educ Res 1996;10:467-478.
21. Dickey LL, Gemson DH, Carney P. Office system interventions supporting primary care-based health behavior change counseling. Am J Prev Med 1999; 17:299-308.
22. Oki JC, Flora DL, Isley WL. Frequency and impact of SMBG on glycemic control in patients with NIDDM in an urban teaching hospital clinic. Diabetes Educ 1997;23:419-424.
23. Simmons D, Peng A, Cecil A, Gatland B. The personal costs of diabetes: a significant barrier to care in South Auckland. N Z Med J 1999;112:383-385.
24. Karter AJ, Ferrara A, Darbinian JA, et al. Self-monitoring of blood glucose. Diabetes Care 2000;23: 477-483.
25. Rizzo JA, Abbott TA, Pashko S. Labour productivity effects of prescribed medicines for chronically ill workers. Health Econ 1996;5:249-265
26. Eastman RC, Javitt JC, Herman WH, et al. Model of complications of NIDDM. Diabetes Care 1997;20: 735-744.
27. Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000;321: 405-412.
28. Testa MA, Simonson DC. Health economic benefits and quality of life during improved glycemic control in patients with type 2 diabetes mellitus. JAMA 1998;280:1490-1496.
29. Smith WR. Evidence for the effectiveness of techniques to change physician behavior. Chest 2000; 118(Suppl 2):8S-17S.
30. Holloway RG, Benesch C, Rush SR. Stroke prevention: narrowing the evidence-practice gap. Neurology 2000;54:1899-1906.
31. Robertson D. The roles of health care teams in care of the elderly. Fam Med 1992;24:136-141.
32. Selby JV, Ray GT, Zhang D, et al. Excess costs of medical care for patients with diabetes in a managed care population. Diabetes Care 1997;20:1396-1402.
33. Nichols GA, Glauber HS, Brown JB. Type 2 diabetes: incremental medical care costs during the 8 years preceding diagnosis. Diabetes Care 2000;23:1654-1659.
34. Krop JS, Saudek CD, Weller WE, et al. Predicting expenditures for Medicare beneficiaries with diabetes. Diabetes Care 1999;22:1660-1666.
35. Levetan C, Ratner R. The economic bottom line on preventive diabetes care. Prac Diabetol 1995;Dec:10-18.
36. Herman WH, Dasbach EJ, Songer TJ, Estman RC. The cost-effectiveness of intensive therapy for diabetes mellitus. Endocrinol Metab Clin North Am 1997;26: 679-695.
37. Gilmer TP, O'Connor PJ, Manning WG, et al. The cost to health plans of poor glycemic control. Diabetes Care 1997;20:1847-1853.
38. WBGH. Diabetes management: making the business case: report of a consultation with business and health leaders. Washington, DC: Washington Business Group on Health, 1999.
39. Steffens B. Cost-effective management of type 2 diabetes: providing quality care in a cost-constrained environment. Am J Manag Care 2000;6(Suppl): S697-S703.
40. Philis-Tsimikas A, Heaton S, Springer J, Dailey G. Nurse management improves diabetes care in a managed care setting [abstract 190-OR]. Diabetes 2000; 49(Suppl 1):A47.
41. Rubin RJ, Dietrich KA, Hawk AD. Clinical and economic impact of implementing a comprehensive diabetes management program in managed care. J Clin Endocrinol Metab 1998;83:2635-2642.
42. Klonoff DC, Schwartz DM. An economic analysis of intervention for diabetes. Diabetes Care 2000;23: 390-404.